5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow fotemustine: new trials by email Literature Review of fotemustine trials Research Report on fotemustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Primary CNS Lymphoma ( FTD ) HD-MTX-Ara-C regimen, FTD regimen - Primary CNS Lymphoma (PCNSL) | Phase 2 | Completed | Mingzhi Zhang | 20 | 2017-03-02 | 2022-03-10 |
| Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib Fotemustine + Vemurafenib - Malignant Melanoma Stage IV | Phase 2 | Completed | Paola Queirolo | 31 | 2013-02-01 | 2016-01-20 |
| A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma bevacizumab [Avastin], fotemustine - Glioblastoma Multiforme | Phase 2 | Completed | Hoffmann-La Roche | 91 | 2011-11-01 | 2016-03-15 |
| A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma Ipilimumab and Fotemustine - Metastatic Malignant Melanoma | Phase 2 | Completed | Italian Network for Tumor Biotherapy | 86 | 2010-06-01 | 2015-05-13 |
| A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma bevacizumab [Avastin], fotemustine - Malignant Melanoma | Phase 2 | Completed | Hoffmann-La Roche | 20 | 2006-12-01 | 2018-12-06 |
Melanoma (3) · Glioblastoma (1)
Hoffmann-La Roche (2) · Italian Network for Tumor Biotherapy (1) · Mingzhi Zhang (1) · Paola Queirolo (1)
Italy (4) · China (1)
Michele Maio, MD, PhD (1) · Paola Queirolo, MD (1)
PMID 21030496, PMID 22894884, PMID 25538176, PMID 26951379, PMID 29552321